Sysmex Corporation ADR (OTCMKTS:SSMXY) Sees Large Growth in Short Interest

Key Points

• Sysmex Corporation ADR experienced a significant rise in short interest, jumping by 145.8% from 2,400 shares to 5,900 shares in August.
• The company's most recent quarterly earnings report revealed an EPS of $0.05, falling short of the expected $0.12, with revenue also below analysts' forecasts at $717.09 million.
• Following recent assessments, Zacks Research upgraded Sysmex from a "strong sell" to a "hold" rating, reflecting a cautious outlook among analysts.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) saw a large increase in short interest in August. As of August 31st, there was short interest totaling 5,900 shares, an increase of 145.8% from the August 15th total of 2,400 shares. Based on an average daily trading volume, of 271,900 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 271,900 shares, the short-interest ratio is currently 0.0 days.

Sysmex Stock Performance

Shares of SSMXY stock opened at $12.72 on Friday. The stock's 50-day moving average is $14.77 and its two-hundred day moving average is $16.83. The firm has a market cap of $8.01 billion, a price-to-earnings ratio of 25.44 and a beta of 1.10. Sysmex has a 1 year low of $12.29 and a 1 year high of $22.00. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). The company had revenue of $717.09 million for the quarter, compared to analysts' expectations of $807.27 million. Sysmex had a return on equity of 10.20% and a net margin of 9.35%. Analysts predict that Sysmex will post 0.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of "Hold".

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.